搜尋
Silexion Therapeutics Corp
SLXNW添加自選
0.030USD
0.0000.00%
收盤 （美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關於 Silexion Therapeutics Corp 公司
Silexion Therapeutics Corp 是一家專注於腫瘤學的生物技術公司。該公司致力於開發治療效果不佳的實體瘤癌症的療法，這些癌症具有突變的 KRAS 致癌基因。KRAS 基因是一種致癌基因，由於其能夠將外部信號傳遞到細胞核，因此參與調節細胞分裂。基於對難治性實體瘤癌症的研究，該公司正在開發一個平臺，專注於使用核糖核酸 (RNA) 干擾療法沉默 KRAS 致癌基因。其主要候選產品 SIL-204B 由局部施用的小干擾 RNA (siRNA) 組成，採用緩釋配方，作爲局部晚期胰腺癌患者的一線治療，與標準治療化療相結合。其臨牀階段研發管線重點治療攜帶 KRAS G12D 或 KRAS G12V 突變且未檢測到轉移的胰腺癌 (PC) 腫瘤。
Silexion Therapeutics Corp簡介
公司代碼SLXNW
公司名稱Silexion Therapeutics Corp
上市日期Feb 17, 2021
CEOMr. Ilan Hadar
員工數量- -
證券類型Company Warrant
年結日- -
公司地址12 Abba Hillel Road
城市RAMAT GAN
上市交易所NASDAQ Capital Market Consolidated
國家Israel
郵編5250606
電話97286286005
網址
公司代碼SLXNW
上市日期Feb 17, 2021
CEOMr. Ilan Hadar
Silexion Therapeutics Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Mitchell Shirvan, Ph.D.
Dr. Mitchell Shirvan, Ph.D.
Chief Scientific and Development Officer
Chief Scientific and Development Officer
--
--
Mr. Ilan Hadar
Mr. Ilan Hadar
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
--
--
Ms. Ruth Alon
Ms. Ruth Alon
Independent Director
Independent Director
--
--
Mr. Dror J. Abramov
Mr. Dror J. Abramov
Independent Director
Independent Director
--
--
Prof. Shlomo Noy
Prof. Shlomo Noy
Independent Director
Independent Director
--
--
Ms. Mirit Horenshtei Hadar, CPA
Ms. Mirit Horenshtei Hadar, CPA
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Prof. Amnon Peled, Ph.D.
Prof. Amnon Peled, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ilan Levin
Mr. Ilan Levin
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Mitchell Shirvan, Ph.D.
Dr. Mitchell Shirvan, Ph.D.
Chief Scientific and Development Officer
Chief Scientific and Development Officer
--
--
Mr. Ilan Hadar
Mr. Ilan Hadar
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
--
--
Ms. Ruth Alon
Ms. Ruth Alon
Independent Director
Independent Director
--
--
Mr. Dror J. Abramov
Mr. Dror J. Abramov
Independent Director
Independent Director
--
--
Prof. Shlomo Noy
Prof. Shlomo Noy
Independent Director
Independent Director
--
--
常見問題
Silexion Therapeutics Corp的前五大股東是誰？
Silexion Therapeutics Corp的前五大股東如下：Dr. Mitchell Shirvan, Ph.D.